CBIO
Catalyst Biosciences Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.
Market Cap: 19.9 Million
Primary Exchange: NASDAQ
Shares Outstanding: 38 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 3216 trading days
From: 2013-12-16 To: 2023-10-30
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|---|---|---|---|---|---|---|---|
| 2022-09-05 | 2022-09-20 | 2022-09-06 | 2022-08-25 | 1.43 | Cash | |||
| 2022-09-21 | 2022-09-20 | 2022-09-06 | 2022-08-25 | 1.43 | Cash | |||
| 2023-01-13 | 2023-01-12 | 2023-01-05 | 2022-12-27 | 0.0 | Cash | |||
| 2023-01-13 | 2023-01-12 | 2023-01-05 | 2022-12-27 | 0.24 | Cash&Stock |
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-02-13 | 15.0 | 1.0 | 15.0 | |||
| 2015-08-21 | 7.0 | 1.0 | 7.0 |